EGFR and lung cancer: In this population‐based cohort study among patients with early‐stage (I–IIIA) non‐small cell lung cancer in Denmark, nearly half of the patients underwent EGFR gene mutation testing at diagnosis of disease, and 8.9% of the tested patients were EGFRm‐positive.